Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2009-10-21
pubmed:abstractText
There is increasing recognition that neurotrophin (NT) signaling occurs in non-neuronal tissues, including airway smooth muscle (ASM). We recently demonstrated that NTs, such as brain-derived neurotrophic factor (BDNF), enhance intracellular Ca2+ ([Ca2+](i)) and force regulation in human ASM. Increased NT expression has been observed in airway diseases, such as asthma and allergy. In the present study, we tested the hypothesis that NTs contribute to inflammation-induced enhancement of ASM contractility. Using human ASM cells and real-time fluorescence [Ca2+](i) imaging, we examined the contribution of the high-affinity tropomyosin-related kinase and low-affinity, pan-NT p75NTR receptors to [Ca2+](i) regulation under control conditions and after exposure to the proinflammatory cytokine TNF-alpha (20 ng/ml). Exposure to TNF-alpha enhanced [Ca2+](i) responses to agonist (acetylcholine, histamine). Exposure to 10 nM BDNF for even 30 minutes substantially and synergistically enhanced TNF-alpha effects on [Ca2+](i) responses to agonist. Small interfering RNA suppression of tropomyosin-related kinase substantially blunted the effect of BDNF on [Ca2+](i) responses to agonist (with greater effect on Ca2+ influx via store-operated Ca2+ entry compared with sarcoplasmic reticulum Ca2+ release) in both control and TNF-alpha-exposed cells. However, p75NTR suppression by small interfering RNA had no significant effect on [Ca2+](i) responses in either cell group. These novel data demonstrate that NTs influence ASM contractility, and suggest a potential role for NTs in airway diseases.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1535-4989
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
41
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
603-11
pubmed:dateRevised
2010-12-3
pubmed:meshHeading
pubmed-meshheading:19213875-Acetylcholine, pubmed-meshheading:19213875-Brain-Derived Neurotrophic Factor, pubmed-meshheading:19213875-Bronchi, pubmed-meshheading:19213875-Calcium Signaling, pubmed-meshheading:19213875-Cells, Cultured, pubmed-meshheading:19213875-Histamine, pubmed-meshheading:19213875-Humans, pubmed-meshheading:19213875-Inflammation Mediators, pubmed-meshheading:19213875-Muscle Contraction, pubmed-meshheading:19213875-Myocytes, Smooth Muscle, pubmed-meshheading:19213875-Nerve Tissue Proteins, pubmed-meshheading:19213875-RNA Interference, pubmed-meshheading:19213875-Receptor, trkB, pubmed-meshheading:19213875-Receptors, Nerve Growth Factor, pubmed-meshheading:19213875-Recombinant Proteins, pubmed-meshheading:19213875-Sarcoplasmic Reticulum, pubmed-meshheading:19213875-Time Factors, pubmed-meshheading:19213875-Tumor Necrosis Factor-alpha
pubmed:year
2009
pubmed:articleTitle
Brain-derived neurotrophic factor in TNF-alpha modulation of Ca2+ in human airway smooth muscle.
pubmed:affiliation
Department of Anesthesiology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA. prakash.ys@mayo.edu
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural